1Campbell NL, Unverzagt F, LaMantia MA, et al. Risk factors for the progression of mild cognitive impairment to dementia [J]. Clinics in Geriatric Medicine, 2013,29 : 873-893.
2Fei M, Jianhua W. Apolipoprotein epsilon4-allele as a significant risk factor for conversion from mild cognitive impairment to Alzheimer's disease: a meta analysis of prospective studies [J]. Journal of Molecular Nneuroscience, 2013,50 : 257-263.
3Serrano CM, Dillon C, Leis A,et al. Mild cognitive impairment., risk of dementia according to subtypes [J]. Actas Espanolas Depsiquiatria, 2013,41:330 -339.
4Shaffer JI., Petrella JR, Sheldon FC, et al. Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers [J]. Radiology, 2013,266:583-591.
5Erten-Lyons D, Howieson D, Moore MM, et al. Brain volume loss in MCI predicts dementia [J]. Neurology, 2006, 66:233-235.
6Jack CR, Shiung MM, Weigand SD, et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI[J]. Neurology,2005,65:1227 -1231.
7Fellgiebel A, Dellani PR, Greverus D, et al. Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus [J]. Psychiatry Research, 2006,146 : 283-287.
8Yetkin FZ, Rosenberg RN, Weiner MF,et al. FMRI of working memory in patients with mild cognitive impairment and probable Alzheimer's disease [J]. European Radiology, 2006,16 : 193-206.
9HanssonO, Zetterberg H, Buchhave P, et al. Association between CSF biomarkers and incipient Alzheimerrs disease in patients with mild cognitive impairment : a follow-up study [J]. Lancet Neuroloav, 2006, 5:228-234.
10Tarawneh R, D'Angelo G, Macy E, et al. Visinin- like protein-1 : diagnostic and prognostic biomarker in Alzheimer disease[J]. Annals of Neurology, 2011, 70:274- 285.
5Koen JD,Yonelinas AR The effects of healthy aging,amnes- tic mild cognitive impairment,and Alzheimer's disease on recollection and familiarity:a meta-analytic review[J].Neuropsychol Review,2014,24(3):332-354.
6Naylor MD,Karlawish JH,Arnold SE,et al.Advancing Alzheimer's disease diagnosis,treatment,and care;recom- mendations from the Ware Invitational Summit[J].Alzhe- imer's & Dementia,2012,8(5):445-452.
7Dubois B,Feldman HH5Jacova C,et al.Advancing research diagnostic criteria for AlzheimeryS disease:the IWG-2 cri- teria[J],Lancet Neurol,2014,13(6):614-629.
8Bateman RJ,Xiong C,Benzinger TL,et al.Clinical and biomarker changes in dominantly in herited Alzheimer's disease[J].N Engl J Med,2012,367(9):795-804.
9Berridge MJ.Calcium regulation of neural rhythms,memo- ry and Alzheimer's disease[J],J Physiol,2014,592(Pt2):281-293,.
10Solomon B,Koppel RtJossiphov J,Immunostaining of calmod- ulin and aluminium in Alzheimer's disease-affected brains[J].Brain Res Bull,2001,55(2):253-256.
